Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion type Assertion NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_head.
- NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion description "[TZDs (thiazolidinediones) are prescribed as anti-Type II diabetes drugs, but little is known regarding whether TZDs regulate the expression of sPLA2 (secretory phospholipase A2) in macrophages.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_provenance.
- NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion evidence source_evidence_literature NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_provenance.
- NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion SIO_000772 19947950 NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_provenance.
- NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion wasDerivedFrom befree-20140225 NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_provenance.
- NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_assertion wasGeneratedBy ECO_0000203 NP504023.RAPy1oghAoX03SdPpEqMb5-vLDjrIPdohR0iJ6s_Hxbe8130_provenance.